P. Hardy

Monitoring individual response to hormone replacement therapy with bone markers.

P. Delmas, P. Garnero, M. Dain, 2000, Bone.

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study.

P. Delmas, R. Balena, C. Hardouin, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal women

D. Felsenberg, P. Delmas, P. Garnero, 1999 .

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial

C. Bottomley, T. Roberts, A. Coomarasamy, 2020, The Lancet.

Three-year follow-up of the use of transdermal 17beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women.

D. Felsenberg, P. Delmas, J. Stakkestad, 2001, American journal of obstetrics and gynecology.

Matrix Delivery Transdermal 17β-Estradiol for the Prevention of Bone Loss in Postmenopausal Women

C. Cooper, P. Delmas, J. Stakkestad, 1999, Osteoporosis International.

Matrix delivery transdermal 17beta-estradiol for the prevention of bone loss in postmenopausal women. The International Study Group.

C. Cooper, P. Delmas, J. Stakkestad, 1999, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

Chlorhexidine vaginal preparation versus standard treatment at caesarean section to reduce endometritis and prevent sepsis—a feasibility study protocol (the PREPS trial)

R. Morris, V. Hodgetts Morton, A. Weckesser, 2018, Pilot and Feasibility Studies.

Cost‐effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial

C. Bottomley, T. Roberts, A. Coomarasamy, 2021, BJOG : an international journal of obstetrics and gynaecology.

Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women ☆ ☆☆

D. Felsenberg, P. Delmas, J. Stakkestad, 2001 .